Advisor Group Holdings, Inc. Liminal Bio Sciences Inc. Put Options Transaction History
Advisor Group Holdings, Inc.
- $42.2 Billion
- Q3 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding LMNL
# of Institutions
2Shares Held
234Call Options Held
0Put Options Held
0About Liminal BioSciences Inc.
- Ticker LMNL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 31,042,600
- Description
- Liminal BioSciences Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel small molecule drug therapeutics for inflammatory, fibrotic, and metabolic diseases in Canada and the United Kingdom. The company's lead product candidate is fezagepras (PBI-4050), which has been completed Phase I clinical trial for the trea...